Senores Pharmaceuticals Share Price
13 Nov, 2026 3:58 PM (IST)
Senores Pharmaceuticals Performance
- Today's Low
- ₹1,165
- Today's High
- ₹1,227
- 52 Week Low
- ₹706
- 52 Week High
- ₹1,599
- Open Price₹1,208
- Previous Close₹1,217
- Volume425,876
- 50 DMA₹1,281.90
- 100 DMA₹1,275.50
- 200 DMA₹1,162.50
Senores Pharmaceuticals Chart
Investment Returns
- Over 1 Month -10.93%
- Over 3 Month -21.29%
- Over 6 Month + 25.91%
- Over 1 Year + 51.25%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 40.5
- PEG Ratio
- 0.8
- Market Cap Cr
- 5,410
- P/B Ratio
- 5.6
- Average True Range
- 59.5
- EPS
- 29
- Dividend Yield
- 0
- MACD Signal
- -40.7
- RSI
- 47.51
- MFI
- 27.52
Latest Stock News Updates
Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026
- BSE India
- 1 week 1 day ago
Senores Pharmaceuticals Limited has informed the exchange regarding Newspaper publication extracts of unaudited financial results for the quarter and half year ended September 30, 2026
- BSE India
- 2 weeks ago
Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026
- BSE India
- 2 weeks ago
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹1,217.10
- 50 Day
- ₹1,281.90
- 100 Day
- ₹1,275.50
- 200 Day
- ₹1,162.50
Resistance and Support
- R3 1,283.40
- R2 1,252.60
- R1 1,234.80
- S1 1,186.20
- S2 1,155.40
- S3 1,137.60
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-10-29 | Quarterly Results | |
| 2026-07-27 | Quarterly Results | |
| 2026-05-14 | Audited Results | |
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
About Senores Pharmaceuticals
Senores Pharmaceuticals is engaged in the business of manufacturing API, trading of pharmaceuticals and allied products and also providing product development services and other management consultancy services. View More- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Popular Stocks
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹1,174 As on 13 November, 2026 | 16:40
The Market Cap of Senores Pharmaceuticals is ₹5409.5 Cr As on 13 November, 2026 | 16:40
The P/E ratio of Senores Pharmaceuticals is 40.5 As on 13 November, 2026 | 16:40
The PB ratio of Senores Pharmaceuticals is 5.6 As on 13 November, 2026 | 16:40
The 52 week High & Low of Senores Pharmaceuticals is ₹1599/₹706 respectively As on 13 November, 2026 | 16:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.